Clinical trials are how treatments move from theory to evidence. For nail biting, the trial landscape is smaller than for major medical conditions — but it’s growing. Here’s what researchers are testing, what they’ve found, and what’s next.
The clinical trial landscape
Nail biting research has a structural challenge: funding. Pharmaceutical companies fund trials when there’s a patentable drug with market potential. Because no drug is specifically developed for nail biting, most trials are investigator-initiated, funded by academic grants or foundations like the NIH.
Searching ClinicalTrials.gov for “onychophagia” or “nail biting” returns modest results. Many BFRB trials include nail biters alongside people with trichotillomania and skin picking, making nail-biting-specific conclusions harder to isolate.
Despite these limitations, meaningful research is happening.
Behavioral therapy trials
Habit Reversal Training (HRT)
The most-studied behavioral intervention for nail biting, with trials dating back to the 1970s.
How it works: Three core components — awareness training (recognizing when and why you bite), competing response training (practicing a physically incompatible behavior like clenching fists), and social support (involving someone who reinforces awareness).
Key results:
A 2013 RCT assigned 40 chronic nail biters to either HRT or waitlist control. The HRT group showed 74% reduction in biting frequency at 8 weeks, sustained at 6-month follow-up.
A 2019 RCT compared in-person versus telehealth HRT for BFRBs. Both produced equivalent outcomes — roughly 60% reduction in severity scores. This matters because telehealth dramatically increases accessibility.
A 2024 trial enhanced standard HRT with mindfulness-based awareness components. The enhanced protocol produced 72% reduction versus 58% for standard HRT, with better maintenance at follow-up.
Acceptance and Commitment Therapy (ACT)
Rather than suppressing urges, ACT teaches people to notice urges without reacting. It emphasizes psychological flexibility — having uncomfortable thoughts and feelings without reflexively responding with habitual behavior.
A 2023 trial in the Journal of Obsessive-Compulsive and Related Disorders tested an 8-session ACT protocol for BFRBs. Nail biting participants showed 55% reduction in biting episodes and significant improvements in well-being. Effect sizes were comparable to HRT.
Comprehensive Behavioral Treatment (ComB)
ComB addresses BFRBs across five domains: sensory, cognitive, affective, motor, and environmental. Treatment is individualized. A 2019 open trial showed significant improvement in 70% of participants. A 2022 trial found both therapist-delivered and self-help workbook versions produced improvement, though therapist-delivered had larger effects.
Pharmacological trials
N-Acetylcysteine (NAC)
An amino acid derivative that modulates glutamate signaling. The rationale: repetitive behaviors may involve dysregulated glutamate in corticostriatal circuits.
A landmark 2009 RCT found NAC significantly reduced hair pulling in trichotillomania, sparking interest for other BFRBs.
A 2024 trial specifically targeting nail biting tested NAC at 1,200 mg twice daily for 12 weeks. Results: statistically significant reduction compared to placebo, with a moderate effect size (Cohen’s d = 0.52). Side effects mild and transient (primarily GI discomfort).
An ongoing multi-site trial is comparing NAC to placebo in chronic onychophagia, with results expected late 2026.
SSRIs
Results have been disappointing for BFRBs as standalone targets:
- A 2010 RCT of fluoxetine for skin picking found no significant benefit over placebo
- A 2019 systematic review concluded SSRIs were not significantly better than placebo for BFRBs used alone
- A 2022 trial found fluoxetine combined with HRT outperformed HRT alone for BFRBs with comorbid anxiety — suggesting SSRIs help the comorbidity, indirectly reducing BFRB severity
Current consensus: SSRIs are worth trying when nail biting co-occurs with anxiety, OCD, or depression. Not a reliable standalone treatment for nail biting itself.
Other agents under investigation
Memantine (glutamate NMDA receptor antagonist): A 2018 open-label study found it reduced BFRB severity in 8 of 14 participants. No double-blind RCTs completed for nail biting.
Inositol: A small 2014 trial found some benefit for trichotillomania. No nail-biting-specific trials published.
Silymarin (milk thistle): A 2019 RCT found it reduced trichotillomania symptoms. BFRB researchers are interested in broader testing.
Digital and technology-based trials
App-based interventions
A 2023 feasibility study tested an app combining awareness logging, CBT exercises, and personalized nudges. Over 8 weeks, nail biting episodes decreased ~35%. Engagement dropped after week 4 — highlighting the adherence challenge.
A 2024 RCT testing a comprehensive app-based HRT program showed the HRT app outperformed tracking-only controls: 47% versus 18% reduction at 8 weeks.
Wearable devices
A 2024 study of a wrist-worn device that vibrates when it detects hand-to-face proximity found 80% increase in awareness and ~30% reduction in biting over 4 weeks. Significant individual variation — some responded strongly, others found alerts annoying.
Computer vision approaches
A 2024 proof-of-concept demonstrated consumer webcams and ML models could detect nail biting gestures with ~85% accuracy in controlled settings. Real-world accuracy and latency remain challenges. Clinical outcome data limited to small pilots.
How to find and join trials
Search resources
- ClinicalTrials.gov — search “onychophagia,” “nail biting,” or “body-focused repetitive behavior.” Filter by status, location, and age.
- TLC Foundation for BFRBs (bfrb.org) — maintains a research participation page
- University psychology and psychiatry departments — many trials aren’t listed on ClinicalTrials.gov
What to expect
- Screening: Questionnaires and possibly interview to confirm eligibility
- Baseline assessment: Documentation of current severity and frequency
- Intervention: Usually 8–16 weeks
- Follow-up: Assessments at trial end and 3–6 months later
- Compensation: Many trials offer it; amount varies
Typical eligibility
Common requirements: adult (18+), chronic daily or near-daily biting for 6+ months, willing to attend visits. Common exclusions: active substance abuse, unstable psychiatric conditions, pregnancy (for pharmacological trials).
The evidence gap
Several important questions remain unanswered:
- Long-term outcomes. Most trials follow participants 3–6 months. What happens at 1, 2, 5 years?
- Treatment matching. Which patients respond best to behavioral vs. pharmacological vs. combined approaches?
- Children and adolescents. The peak prevalence population is understudied.
- Combination therapies. Limited data on combining behavioral and pharmacological approaches specifically for nail biting.
- Real-world effectiveness. Trial volunteers are motivated and meet strict criteria. How well do these interventions work in general practice?
These gaps represent both a limitation and an opportunity for future research.
Frequently asked questions
Are there clinical trials specifically for nail biting?
Yes, but they're rare compared to trials for other conditions. Most nail-biting-specific trials study behavioral interventions like Habit Reversal Training. Pharmacological trials more commonly study BFRBs as a group. ClinicalTrials.gov lists active and completed trials searchable by "onychophagia" or "nail biting."
How can I participate in a nail biting clinical trial?
Search ClinicalTrials.gov for "onychophagia" or "nail biting" and filter for recruiting studies. The TLC Foundation for BFRBs also lists active trials. Most require you to be an adult with chronic nail biting. Participation is typically free and may include compensation.
What medications are being tested for nail biting?
N-acetylcysteine (NAC) has the most active research interest. Other compounds under investigation include memantine, inositol, and various glutamate-modulating agents. SSRI trials continue with inconsistent results. No medication is currently FDA-approved for nail biting.
Do clinical trials for nail biting actually work?
Results vary by intervention. Behavioral therapy trials (HRT, ACT) consistently show 50-90% reduction in biting frequency. Pharmacological trials are more mixed — NAC trials are moderately positive, SSRI trials inconsistent. Digital intervention trials are early-stage but promising.